Όλο το DSpace

Πλοήγηση ανά Θέμα "antiandrogen"

Αποτελέσματα 1-7 από 7

    • Adverse effects of androgen deprivation therapy in patients with prostate cancer: Focus on metabolic complications 

      Tzortzis V., Samarinas M., Zachos I., Oeconomou A., Pisters L.L., Bargiota A. (2017)
      Prostate cancer is the most common cancer among men and androgen deprivation therapy (ADT) is the most effective treatment for this disease. The cornerstone of the treatment of prostate cancer is inhibition of testosterone ...

    • Drug-induced endocrinopathies and diabetes: A combo-endocrinology overview 

      Diamanti-Kandarakis E., Duntas L., Kanakis G.A., Kandaraki E., Karavitaki N., Kassi E., Livadas S., Mastorakos G., Migdalis I., Miras A.D., Nader S., Papalou O., Poladian R., Popovic V., Rachoń D., Tigas S., Tsigos C., Tsilchorozidou T., Tzotzas T., Bargiota A., Pfeifer M., on behalf of COMBO ENDO TEAM: 2018 (2019)
      In the currently overwhelming era of polypharmacy, the balance of the dynamic and delicate endocrine system can easily be disturbed by interfering pharmaceutical agents like medications. Drugs can cause endocrine abnormalities ...

    • The effects of old, new and emerging medicines on metabolic aberrations in PCOS 

      Bargiota, A.; Diamanti-Kandarakis, E. (2012)
      Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age that is associated with significant adverse short- and long-term health consequences. Multiple metabolic aberrations, such as ...

    • Expression of Fibroblast Activation Protein Is Enriched in Neuroendocrine Prostate Cancer and Predicts Worse Survival 

      Vlachostergios P.J., Karathanasis A., Tzortzis V. (2022)
      Background: Advanced prostate cancer (PC) may accumulate genomic alterations that hallmark lineage plasticity and transdifferentiation to a neuroendocrine (NE) phenotype. Fibroblast activation protein (FAP) is a key player ...

    • Late results of a randomized trial on the role of mild hypofractionated radiotherapy for the treatment of localized prostate cancer 

      Alexidis P., Karatzoglou S., Dragoumis D., Drevelegas K., Tzitzikas I., Hatzimouratidis K., Chrisogonidis I., Ioannidis A., Katsios I.N., Zarogoulidis P., Sapalidis K., Koulouris C., Michalopoulos N., Giannakidis D., Aidoni Z., Fyntanidou V., Amaniti A., Boniou K., Kesisoglou I., Vagionas A., Romanidis K., Oikonomou P., Goganau A.M., Petanidis S., Maragouli E., Kosmidis C. (2020)
      Background: Prostate cancer is considered to be highly sensitive to changes in radiation therapy dose per fraction, specifically to hypofractionation. An increase in the fractionation dose could cause a higher increase to ...

    • Prostate cancer: ESMO consensus conference guidelines 2012 

      Horwich, A.; Hugosson, J.; de reijke, T.; Wiegel, T.; Fizazi, K.; Kataja, V.; Parker, C.; Bellmunt, J.; Berthold, D.; Bill-axelson, A.; Carlsson, S.; Daugaard, G.; De meerleer, G.; De reijke, T.; Dearnaley, D.; Fonteyne, V.; Gillessen, S.; Heinrich, D.; Kwiatkowski, M.; Nilsson, S.; Padhani, A.; Papandreou, C.; Roobol, M.; Sella, A.; Valdagni, R.; Van der kwast, T.; Verhagen, P. (2013)
      The first ESMO Consensus Conference on prostate cancer was held in Zurich, Switzerland, on 17-19 November 2011, with the participation of a multidisciplinary panel of leading professionals including experts in methodological ...

    • The role of hypofractionated radiotherapy for the definitive treatment of localized prostate cancer: Early results of a randomized trial 

      Alexidis P., Dragoumis D., Karatzoglou S., Drevelegas K., Tzitzikas I., Hatzimouratidis K., Chrisogonidis I., Giannakidis D., Koulouris C., Katsaounis A., Michalopoulos N., Huang H., Li Q., Aidoini Z., Fyntanidou V., Amaniti A., Hohenforst-Schmidt W., Maragouli E., Petanidis S., Zarogoulidis P., Sapalidis K., Kosmidis C., Romanidis K., Oinkonomou P., Vagionas A., Nikolaos-Katsios I., Ioannidis A., Boniou K., Kesisoglou I. (2019)
      Background: Prostate cancer is considered to have a special biology which could affect the radiation therapy result based on the selected fractionation scheme. We present the preliminary results of a randomized trial ...